Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2023 15:47 ET | Source: Portnoy Law

Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc....
November 01, 2023 20:03 ET | Source: Portnoy Law

Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc....
October 05, 2023 14:59 ET | Source: Robbins LLP

Tandem Diabetes Care, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Tandem Diabetes Care, Inc.; Contact Robbins LLP Today

Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections
September 28, 2023 11:05 ET | Source: Robbins LLP

TNDM Shareholders Who Have Lost Money in the Stock Should Contact Robbins LLP for Information About the Class Action Against Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections
September 21, 2023 18:52 ET | Source: Robbins LLP

TNDM Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Recovery Against Tandem Diabetes Care, Inc.

SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes...
September 15, 2023 13:52 ET | Source: Robbins LLP

Tandem Diabetes Care, Inc. (TNDM) Investor Alert: Robbins LLP Reminds Investors of Class Action Filed Against Tandem Diabetes Care, Inc.

SAN DIEGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes...